Brian Lian - 19 Apr 2023 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Signature
/s/ Michael Morneau, as Attorney-in-Fact
Issuer symbol
VKTX
Transactions as of
19 Apr 2023
Net transactions value
-$750,750
Form type
4
Filing time
21 Apr 2023, 19:29:11 UTC
Previous filing
18 Apr 2023
Next filing
01 May 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VKTX Common Stock, par value $0.00001 per share Sale $750,750 -35,000 -1.5% $21.45 2,242,963 19 Apr 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person.